A Phase II Trial of Pictilisib with Chemotherapy in First-Line Squamous NSCLC

被引：0

作者：

Spigel, David ^{[1
]}

Luft, Alexander ^{[2
]}

Vynnychenko, Ihor ^{[3
]}

Fadeeva, Natalia ^{[4
]}

Mark, Zsuzsanna ^{[5
]}

Ponce, Santiago ^{[6
]}

Matrosova, Marina ^{[7
]}

Goldschmidt, Jerome ^{[8
]}

Szima, Barna ^{[9
]}

Saleh, Mansoor ^{[10
]}

Lackner, Mark ^{[11
]}

Gendreau, Steve ^{[11
]}

Bassett, Katia ^{[11
]}

Spoerke, Jill ^{[11
]}

Koeppen, Hartmut ^{[11
]}

Gilbert, Houston ^{[11
]}

Jin, Huan ^{[11
]}

Shankar, Geetha ^{[11
]}

Lin, Wei ^{[11
]}

Denis, Fabrice ^{[12
]}

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] Leningrad Reg Clin Hosp, St Petersburg, Russia

[3] Sumy State Univ, Sumy, Ukraine

[4] Chelyabinsk Reg Clin Oncol Dispensary, Chelyabinsk, Russia

[5] Tudogyogyintezet Torokbalint, Torokbalint, Hungary

[6] Hosp Univ 12 Octubre, Madrid, Spain

[7] N Novgorod Reg Oncol Dispensary, Novgorod, Russia

[8] US Oncol Network, Marion, VA USA

[9] Markusovszky Hosp, Szombathely, Hungary

[10] Georgia Canc Specialists, Marietta, GA USA

[11] Genentech Inc, San Francisco, CA 94080 USA

[12] Victor Hugo Clin, Jean Bernard Ctr, Le Mans, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

squamous; metastatic; P13K; Placebo-controlled;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MINI30.13

引用

页码：S375 / S375

页数：1